Some studies have emphasized the significance of a comprehensive evaluation of PD-L1 expression on tumor and immune cells because its expression in immune cells, but not tumor cells, is a favorable prognostic factor for NSCLC and HNSCC [55,56,57]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.